| 000 | 00889 a2200241 4500 | ||
|---|---|---|---|
| 005 | 20250514025820.0 | ||
| 264 | 0 | _c20020828 | |
| 008 | 200208s 0 0 eng d | ||
| 022 | _a1470-269X | ||
| 024 | 7 |
_a10.1038/sj.tpj.6500027 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAmouyel, P | |
| 245 | 0 | 0 |
_aA critical assessment of the role of pharmacogenomics and pharmacogenetics approaches to cardiovascular diseases. _h[electronic resource] |
| 260 |
_bThe pharmacogenomics journal _c2001 |
||
| 300 |
_a95-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aCardiovascular Diseases _xgenetics |
| 650 | 0 | 4 |
_aGenomics _xtrends |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPharmacogenetics _xtrends |
| 773 | 0 |
_tThe pharmacogenomics journal _gvol. 1 _gno. 2 _gp. 95-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.tpj.6500027 _zAvailable from publisher's website |
| 999 |
_c11816927 _d11816927 |
||